Liver disease in Navajo neuropathy

Journal of Pediatrics

Volumn 135, Issue 4, 1999, Pages 482-493

  Holve, Steve ^a,b,c   Hu, Diana ^a,b,c   Shub, Mitchell ^a,b,c   Tyson, R Weslie ^a,b,c   Sokol, Ronald J ^a,b,c  

^a Tuba City Indian Medical Center   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; INFANT; LIVER DISEASE; NEUROPATHY; NOMENCLATURE; ONSET AGE; PRIORITY JOURNAL;

EID: 0033497512     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70172-1     Document Type: Article

References (29)

1. 1. Appenzeller O, Kornfeld M, Snyder R. Acromutilating, paralyzing neuropathy with corneal ulceration in Navajo children. Arch Neurol 1976;24:733-8.
2. 2. Singleton R, Helgerson S, Snyder R, O'Connor PJ, Nelson S, Johnsen S, et al. Neuropathy in Navajo children: clinical and epidemiologic features. Neurology 1990;40:366-7.
3. 3. Snyder RD, Appenzeller O, Johnson PC. Infantile onset and late central white matter lesions in Navajo neuropathy. Ann Neurol 1988;24:327.
4. 4. Williams K, Drayer B, Johnsen S. MR imaging of leukoencephalopathy associated with Navajo neuropathy. AJNR Am J Neuroradiol 1990;11:400-2.
5. 5. Andres JM. Hepatocyte injury and giant cell transformation. In: Suchy FJ, editor. Liver disease in children. St Louis: Mosby-Year Book; 1994. p. 166-72.
6. 6. Scheuer PJ. Liver biopsy interpretation. London: Balliere Tindall; 1980. p. 36-59.
7. 7. Balistreri WF, Schubert WK. Liver disease in infancy and childhood. In: Schiff L, Schiff ER, editors. Diseases of the liver. Philadelphia: Lippincott; 1993. p. 1099-203.
8. 8. Johnston DF. An analysis of sources of information on the population of the Navaho. Smithsonian Institution, Bureau of Ethnology, bulletin 197. Washington (DC): Government Printing Office; 1966. p. 73-6.
9. 9. Link M. Hwelte. Window Rock (AZ): Navajo Tribal Museum; 1971. p. 10-4.
10. 10. Kluckhorn C, Leighton D. The Navajo. London: Harvard University Press; 1946. p. 71.
11. 11. Howard C. Navajo tribal demography. New York: Garland Publishing; 1993. p. 67-70.
12. 12. Paster-Soler N, Rafi M, Hoffman J, Hu D, Wenger, D. Metachromatic leukodystrophy in the Navajo Indian population: a splice site mutation in the arylsulfatase A gene. Hum Mutat 1994;4:199-207.
13. 13. Li L, Drayna D, Hu D, Hayward A, Gahagan S, Pabst H, et al. The gene for Athabascan SCIDS is located on chromosome 10p. Am J Hum Genet 1998;62:136-44.
14. 14. Sokol RJ. Vitamin E deficiency and neurologic disorders. In: Packer L, Fuchs J, editors. Vitamin E in health and disease. New York: Marcel-Dekker; 1993. p. 815-50.
15. 15. Wilson JD. Deficiency of vitamins A and K. In: Isselbacher K, Adams R, Braunwald E, Petersdorf R, Wilson JD, editors. Harrison's principles of Internal medicine. New York: McGraw-Hill; 1980. p. 431.
16. 16. Moore JW, Dunk AA, Crawford JR, Deans H, Besson JA, De Lacey G, et al. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study. J Hepatol 1989;9:319-25.
17. 17. Sveger T. Prospective study of children with alpha 1 antitrypsin deficiency: eight year follow-up. J Pediatr 1984;104:91-4.
18. 18. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992;117:641-7.
19. 19. Clayton R, Iber F, Ruebner B, McKusick V. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969;117:112-23.
20. 20. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
21. 21. Weber A, Tuchweber B, Yousef I, Brochu P, Turgeon C, Roy C, et al. Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction. Gastroenterology 1981;81:653-62.
22. 22. Bull LN, Carlton VEH, Stricker NL, Baharloo S, De Young JA, Freimer NB, et al. Genetic and morpholgical findings in progressive intahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-64.
23. 23. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nature Genetics 1998;20:233-8.
24. 24. De Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998;95:282-7.
25. 25. Zhang X, Arias IM. Deficient MDR3 expression in liver from patients with Navajo neuropathy: a human homolog of mdr2-/-mice [abstract]. Hepatology 1997;26:369A.
26. 26. Alpers BJ. Diffuse progressive degeneration of the gray matter of the cerebrum. Arch Neurol Psychiatry 1931; 25:469-505.
27. 27. Narkewicz M, Sokol RJ, Beckwith B, Sondheimer J, Silverman A. Liver involvement in Alpers disease. J Pediatr 1991;119:260-7.
28. 28. Sokol R, Narkewicz M. Mitochondrial hepatopathies. In: Suchy FJ, editor. Liver disease in children. St Louis: Mosby-Year Book; 1994. p. 888-96.
29. 29. Treem WR, Sokol RJ. Disorders of mitochondria. Semin Liver Dis 1998; 18:237-53.